Skip to main content
PLOS One logoLink to PLOS One
. 2023 Oct 12;18(10):e0292968. doi: 10.1371/journal.pone.0292968

What do people living with chronic pain want from a pain forecast? A research prioritization study

Claire L Little 1, Katie L Druce 1, William G Dixon 1,2, David M Schultz 3,4,*, Thomas House 5, John McBeth 1,2
Editor: Shadia Hamoud Alshahrani6
PMCID: PMC10569639  PMID: 37824568

Abstract

Because people with chronic pain feel uncertain about their future pain, a pain-forecasting model could support individuals to manage their daily pain and improve their quality of life. We conducted two patient and public involvement activities to design the content of a pain-forecasting model by learning participants’ priorities in the features provided by a pain forecast and understanding the perceived benefits that such forecasts would provide. The first was a focus group of 12 people living with chronic pain to inform the second activity, a survey of 148 people living with chronic pain. Respondents prioritized forecasting of pain flares (100, or 68%) and fluctuations in pain severity (94, or 64%), particularly the timing of the onset and the severity. Of those surveyed, 75% (or 111) would use a future pain forecast and 80% (or 118) perceived making plans (e.g., shopping, social) as a benefit. For people with chronic pain, the timing of the onset of pain flares, the severity of pain flares and fluctuations in pain severity were prioritized as being key features of a pain forecast, and making plans was prioritized as being a key benefit.

Introduction

Chronic pain (i.e., pain lasting at least three months) is experienced by an estimated 43% of adults in the United Kingdom [1, 2]. Chronic pain conditions are associated with significant individual and societal burden. They are among the leading causes of disability globally [3], with an estimated 568 million global cases of lower-back pain alone in 2019 [4]. Individuals report that pain interferes with their professional and social lives, affects their relationships, and decreases their quality of life, mood and sleep [5]. In the UK, 13.4% of sickness days were due to musculoskeletal conditions in 2021 [6]. Although up-to-date figures are scarce, the economic costs of chronic pain are considerable. For example, chronic pain conditions cost 1.5–3% of European GDP in 2012 [7].

The severity of chronic pain is a key driver of outcome, with more severe pain associated with worse outcomes including poorer physical and mental health–related quality of life [8–10], mood [11–13], and social and work participation [14, 15]. However, the absolute level of pain severity is not the only important driver of outcome. Variability in pain severity is also an important factor. The severity of chronic pain is not stable over time, and individuals experience intra- and inter-daily fluctuations in pain severity and pain flares which are characterized by a rapid increase in pain severity [16–22]. People living with chronic pain report that the variability in pain severity is unpredictable, and this unpredictability leads to feelings of uncertainty [23, 24] that permeates every sphere of their lives through a decreased ability to work, missed social events, and avoidance in making commitments [25, 26]. There is a clear desire to reduce the unpredictability of pain severity, with patients often asking how their pain might manifest in the future.

Pain is a complex biopsychosocial phenomenon and predicting variability in pain severity, including pain flares, will be challenging. It will involve identifying and understanding the complex relationship between time-varying biological, psychological and social exposures, discerning how those are associated with changes in pain severity over time, and developing models to forecast those changes. We propose that a personalized pain-forecasting model could reduce pain-related uncertainty by providing predictions of future pain. We have identified factors that are associated with variability in pain severity and could be used as predictors in such a model, including prior pain experience, physical activity [27, 28], mood [29, 30], sleep quality [31] and environmental exposures (here, the weather) [32].

Recent developments in digital data collection tools offer a solution to capturing these data. Patient-generated health data in chronic pain are already used to track daily symptoms including pain symptoms over time [33], to inform models of care [34] and to facilitate conversations between clinicians and patients [35]. Other spheres have shown the feasibility of using patient generated health data to forecast symptoms. For example, individualized prediction models exist for forecasting the diagnosis and prognosis of COVID-19 [36], the presence of anxiety and depression [37], the severity of hay-fever symptoms [38] and the level of physical fatigue [39]. It is feasible that patient-generated health data could also be used to forecast the variability in pain severity. However, the features that a pain forecasting model should predict are not yet clear.

There are many potential pain features that could be predicted by a pain-forecasting model including, for example, the level of forecasted pain severity described as an absolute value, the level of change in forecasted pain severity described as an absolute or proportional increase, the timing of that change, and the variability in pain severity over time. It is not clear which, if any, of these features people living with chronic pain would prioritize in a pain forecast. Patient and Public Involvement (PPI) is defined as work done with members of the public and can be conducted to involve stakeholders in the research process, including in identifying research priorities [40, 41]. Conducting PPI in the process of developing a pain forecast would ensure that the forecast is suited to the needs and priorities of its users [42]. Thus, identifying and prioritizing pain features in PPI activities forms the first stage in producing a pain-forecasting model.

The objectives of this work were to design the content of a pain forecast by (1) learning participants’ priorities in the features of pain severity provided by a pain forecast and (2) understanding the benefits that participants perceive they would gain from such a forecast.

Materials and methods

Two PPI activities were conducted with individuals with chronic pain. The first PPI activity was a focus group to inform the second PPI activity, a survey of people living with chronic pain. The aim of the focus group was to identify potential pain features that could be produced by a pain forecast and a list of potential benefits of a pain forecast. The aim of the survey was to prioritize these features and benefits in a larger sample of people living with chronic pain. These PPI activities were approved by the Proportionate University Research Ethics Committee at the University of Manchester (Ref: 2021-11862-19751). The activities are reported in line with the GRIPP2 (Guidance for Reporting Involvement of Patients and the Public) checklist [41].

Focus group

A semi-structured focus group was conducted with individuals with chronic pain to produce a list of meaningful pain features that could be provided by a forecast and to understand the perceived potential benefits of a forecast. A focus group was chosen as it allowed us to explore reasons behind the choices and to allow participants to build on each other’s ideas [43]. A single focus group was conducted due to time and budget constraints.

We sought to recruit up to 12 individuals who were at least 18 years old, who self-reported having a noncancer chronic-pain condition, lived in the UK, and could read English. Participants were recruited through social media and shared through professional social media accounts of colleagues. We also asked charity organizations related to noncancer chronic-pain conditions (Table 1) to share the survey information through their newsletters and social-media channels, although we do not know if they did, how often they did, and how many people received that information. Potential participants completed a screening questionnaire, providing demographic information on their gender, ethnic group, age bracket (18–25, 26–45, 46–65 or 66+), self-reported chronic-pain condition(s) from a multiple-choice list and length of time since diagnosis. Participants for the focus group were then selected using purposive sampling, ensuring variation in age, gender, ethnic group, number and type of chronic-pain condition(s) and time since diagnosis. Recruited individuals provided informed written consent and were reimbursed for their time and expenses, in line with PPI guidelines from the National Institute for Health and Care Research [44].

Table 1. Charity organizations that advertised the study.

Charity organisation Method of advertisement
Action for ME Website, Twitter, Facebook
Arthritis Action Website
Arthritis and Musculoskeletal Alliance (ARMA) Newsletter, Twitter
Backcare Website
Lupus UK Online forum
Migraine Trust Website, Twitter, Facebook
National Axial Spondyloarthritis Society (NASS) Website, Newsletter
National Rheumatoid Arthritis Society (NRAS) Website, Twitter, Facebook, Instagram
People in Research Website
Postural Tachycardia Syndrome UK (PoTS UK) Twitter, Facebook
PsAZZ Support Group Contacted network
Scleroderma & Raynaud’s UK (SRUK) Twitter, Facebook
The Erythromelgalgia Warriors Website, Twitter, Facebook
UK Gout Society Twitter
Vocal Contacted network

The focus group took place in August 2021 and lasted approximately 90 minutes. Due to the ongoing COVID-19 pandemic, the focus group was held online using Zoom. Three researchers (authors CL, KD and JM) co-facilitated the focus group and made written, anonymized field notes.

The structure of the focus group is provided in Table 2. Discussion topics focused on the pain features of a forecast that participants identified as potentially beneficial, how a forecast could be used in day-to-day life and how the survey (the second PPI activity) should be structured. These discussions led to revisions of the survey, details of which are provided in the results section. The structure of the focus group included a general group-level introduction (facilitated by CL), breakout-room discussions (facilitated by CL, KD and JM), and a final group-level discussion.

Table 2. Planned structure of the focus group.

Section of focus group Purpose Example questions/statements Anticipated duration (mins)
Introduction and general overview
  • Greeting

  • Use of Zoom

  • Review of ground rules

  • Ice breaker

  • Zoom: how to use hands up function

  • We sent around some ground rules as suggested by the university. Is there anything that is missing that you would like to add?

20
Introduction to our ideas
  • Outline the context of research

  • Explain proposed research

Presentation 5
Breakout rooms
  • Understand initial thoughts about the research and perceived interest in different predictands

  • Here are some common patterns of pain severity. Which one(s) do you relate to?

  • What pain features would you want to know about?

15
Break 10
Group discussion
  • Bring thoughts from breakout rooms together

  • What pain features did you come up with?

  • Were there any in other groups that you think are good that you hadn’t thought of?

15
Building a questionnaire
  • Outline of a questionnaire that would be meaningful

  • We want to build a questionnaire to ask other people what information they would like to know about pain patterns in the future. Here are some example questions that we have thought of

  • Are there any questions here that you think we should remove?

  • Are there any questions that we should include?

  • What possible answers should we have?

  • What information would you add or remove to the images to make them clearer?

20
Conclusion
  • Thank participants & let them know what the next steps are

5

Group-level discussions in the focus group were audio-recorded through Zoom, without video recordings, and subsequently transcribed verbatim by CL. Field notes from breakout rooms were made by all facilitators. Participants’ views on potential features of a pain forecast, and how a forecast may be used in day-to-day life were noted and subsequently used to inform multiple-choice questions in the survey.

Survey

The second PPI activity was a survey of people living with chronic pain. This survey aimed to learn participants’ priorities regarding the potential features and perceived benefits of a pain forecast, using the features and benefits identified by the focus group participants.

The survey was distributed in October and November 2021. The recruitment strategy was identical to that of the focus group. Members of the focus group were not prohibited from completing the survey. Consent was provided electronically at the start of the survey, and only complete surveys were analyzed. We aimed to receive at least 100 completed surveys.

The survey collected demographic information and included priority-setting questions and multiple-choice questions. The demographic information collected were participants’ gender, age, chronic pain condition(s) and site(s) of pain. Priority-setting questions asked participants to order multiple-choice options in preference order, using a drag-and-drop feature. Multiple-choice questions asked participants to select one or multiple options, with free-text space for further elaboration if required. Priority-setting and multiple-choice questions were written following discussions in the focus group, and so details are deferred to the Results section. No formal validation on the survey questions were performed. More generally, however, these questions and the answer selections on the survey arose from discussions within the focus group. That should have helped ensure that the questions were informed by conversations with people living with chronic pain. The survey was created in Qualtrics, and a link was shared on social media and with the charities listed in Table 1. The full survey can be viewed in the S1 Data.

Analysis of the survey questions was conducted descriptively. For priority-setting questions, the distribution of respondents prioritizing each option as most important to least important was calculated. For multiple-choice questions, the number and percentage of participants selecting each response was calculated. Sensitivity analyses using chi-squared tests were conducted to compare the responses of participants with commonly reported pain conditions to those without. No matching to the sample characteristics was performed during the analysis. Due to the small number of free-text responses, they were not directly analyzed but are reported following the relevant questions.

Results

Focus group

Demographic data of the 12 participants are provided in Table 3. There were nine females and three males, with all age brackets (18–25, 26–45, 46–65 or 66+) represented. Six participants had been living with chronic pain for at least five years, and five participants had two or more chronic-pain conditions. Chronic-pain conditions of the participants included osteoarthritis, chronic headache, fibromyalgia, neuropathic pain, rheumatoid arthritis, and spondyloarthritis.

Table 3. Demographics of focus group participants (n = 12).

Number of participants
Age
 18–25 1
 26–45 3
 46–65 6
 66+ 2
Gender
 Female 9
 Male 3
Ethnicity
 Asian British 1
 Black British 1
 British Chinese 1
 South Asian 1
 White British 7
 White British & Black African 1
Number of chronic pain conditions
 1 7
 2 or more 5
Chronic pain condition *
 Chronic headache 2
 Fibromyalgia 2
 Neuropathic pain 2
 Osteoarthritis 5
 Rheumatoid Arthritis 2
 Spondyloarthritis 2
 Other 3
Time since diagnosis
 Under 5 years 6
 5 or more years 6

*Column exceeds 100% since participants can have multiple chronic pain conditions

Discussions in the focus group were centered on three overarching themes: the pain features, if any, that participants wanted a forecast to provide, the perceived benefits of a forecast, and the potential drawbacks of using a forecast in daily life. These themes are discussed in more detail below, followed by the implications they had on the survey questions.

The first overarching theme that participants discussed was the pain features of a forecast. Participants described pain features of interest in relation to periods of pain flares (when pain severity increased for a number of days) and periods of low or no pain severity (when pain severity decreased for a number of days). First, they spoke about the timing of these periods (such as when a period of low pain might begin), as this would have implications on activities that could be undertaken, and may impact how work and social activities could be managed in advance:

P6 (F66+): “I gave an example of a [colleague] at the moment who’s got a frozen shoulder and she’ll be coming back on a phased return but the timing of that may be helpful through the [forecast]”

Second, they discussed the duration of pain severity at high or low levels. Knowledge about the duration of pain severity at certain levels would also allow participants to plan activities and relevant interventions. For example, a participant in a breakout room commented that they may visit a chiropractor if their pain was predicted to last for a substantial period of time.

Third, participants wanted to know information about their pain-related quality of life and other symptoms (such as fatigue). Participants in breakout rooms noted that these other symptoms were not always correlated to pain severity and wanted to know information about them separately.

P9 (F46–65): “I think you should maybe focus on quality of life. We all have different levels of pain, different levels of fatigue, we are all different. But what is important for me is totally different to the next person… It’s on what you would accept as a quality of life”

The second overarching theme that participants explored were the perceived benefits of a pain forecast. The most commonly reported benefit of a forecast was that it could improve the ability to make plans, including meeting family, planning grocery shopping, planning pharmacological interventions, organizing nonpharmacological interventions and adapting work:

P3 (F26–45): “For me… the biggest advantage would be planning medication… I tend to go for the lowest meds, and then regret it because I’m still in pain and, oh God, now I can’t take this, or I could take it but then I have stomach issues, all the rest of it. So… if I could get my drugs more accurate to how it’s going to be, my pain medication, my PMR [steroid medication], that would really help, I think.”

Another reported benefit was that participants hoped a forecast might support them in understanding triggers of pain, including how variables such as weather, stress and exercise might affect pain severity. In breakout rooms, participants discussed the empowerment granted through understanding their own triggers of pain.

In the third overarching theme, participants identified potential drawbacks of a pain forecast. First, participants highlighted potential mental-health challenges, such as anxiety and stress induced by having information about pain events, including pain flares:

P3 (F26–45): “There are mental health disadvantages like anticipatory anxiety if the [forecast] tells you you’re going to feel rubbish in a week.”

Among these concerns, participants voiced fears of a self-fulfilling prophecy if they expected pain severity to increase.

Other participants highlighted mental-health challenges related to inputting pain-severity scores, which may encourage higher focus on the pain that they are trying to manage.

Second, participants were anxious about the potential implications of data collection during a pain forecast and fears of data sharing with employers and government officials:

P7 (F46–65): “Who has access to the data? I think it would put a lot of people off if people thought that employers are going to have access to this data.”

P6 (F66+): Would it be “used by occupational health departments in organizations?”

Based on the discussion of the focus group, priority-setting and multiple-choice questions for the survey were written. Of the three overarching themes, questions were developed regarding the potential features and benefits of a pain forecast. As the drawbacks related to the implementation of a pain forecast, these were not included in the present survey. All suggested pain features of the focus group discussion were included, asking survey participants to prioritize the importance of timing, duration and symptoms during periods of low pain and pain flares. All reported benefits were included, asking survey participants to select which benefits applied to them regarding planning, applying pharmacological and nonpharmacological interventions and understanding triggers of pain.

Survey

There were 148 respondents to the survey. Demographic information and data regarding chronic pain condition can be found in Table 4. Of the 148 respondents, 134 (90.5%) of respondents were female and 101 (80%) were aged between 36 and 65. The most commonly reported chronic-pain conditions were fibromyalgia (68, or 46%) and osteoarthritis (49, or 33%). Nine participants (6%) reported only ‘other’ pain conditions. These participants reported ankylosing spondylitis, psoriatic arthritis, scleroderma, systemic lupus erythematosus, and juvenile arthritis.

Table 4. Demographics and chronic pain condition of survey respondents (n = 148).

Number of participants Percentage of participants
Age 18–25 11 7.4%
26–35 19 12.8%
36–45 34 23.0%
46–55 27 18.2%
56–65 40 27.0%
66+ 17 11.5%
Gender Male 13 8.8%
Female 134 90.5%
Nonbinary/third gender 1 0.7%
Chronic pain condition* Fibromyalgia 68 46.0%
Osteoarthritis 49 33.1%
Chronic headache 32 21.6%
Neuropathic pain 28 18.9%
Rheumatoid Arthritis 19 12.8%
Spondyloarthritis 17 11.5%
Unspecific Arthritis 12 8.1%
Other 69 46.6%

*Column exceeds 100% since participants can have multiple chronic pain conditions.

Results of the multiple-choice question “Which of the following would you like a pain forecast to provide for you?” are shown in Table 5. The most commonly selected features were pain flares (100, or 68%) and fluctuations in pain severity (94, or 64%). Features of pain severity on an ordinal scale (70, or 47%) and periods of low pain (51, or 35%) were less commonly selected.

Table 5. Responses to the question: "Which of the following would you like a pain forecast to provide for you?".

Participants could select more than one option.

Pre-specified response Number (and percentage) of full population who selected response Number (and percentage) of subgroup with fibromyalgia who selected response Number (and percentage) of subgroup with osteoarthritis who selected response
Information about a pain flare 100 (67.6%) 47 (69.1%) 34 (69.4%)
Information about fluctuations in pain severity 94 (63.5%) 47 (69.1%) 27 (55.1%)
Information about pain severity on a scale of 1 to 5 70 (47.3%) 30 (44.1%) 23 (46.9%)
Information about a period of low/no pain severity 51 (34.5%) 25 (36.8%) 15 (30.6%)
Other/None 13 (8.8%) 5 (7.4%) 5 (10.2%)

Recognizing that a large proportion of our respondents reported fibromyalgia (46%) and osteoarthritis (33%) as a chronic pain condition, we conducted sensitivity analyses to compare (1) the responses between those respondents who reported fibromyalgia as a pain condition and those that did not and (2) the responses between those respondents who reported osteoarthritis as a pain condition and those that did not. We reported the number and percentage of respondents in the disease subgroups who selected each response and performed a chi-squared test to test whether these responses were significantly different from those not in the corresponding subgroup. Comparing participants reporting fibromyalgia against those not reporting fibromyalgia gave a p-value of 0.2414. For the same question, a chi-squared test of the responses from participants reporting osteoarthritis against those not reporting osteoarthritis gave a p-value of 0.2202. Therefore, there is no evidence that the subgroups gave statistically significantly different responses to the population.

Only two relevant free-text responses were provided to this question, both referring to fluctuations in pain severity:

  • “Will my future pain graphs differ from those in the past?”

  • “Compare it to half hour ago, a couple of hours ago, yesterday etc. with a higher lower method”

Results of the priority-setting question “If we could predict a pain flare, what specific information would you want to know?” are shown in Fig 1. The respondents ranked six statements. Onset of a pain flare was the first priority for 92 (62%) of respondents. Severity of a pain flare was the first or second priority for 74 (50%) of respondents. Pain-related quality of life and variation in other symptoms were given fifth or sixth priority by 104 (70%) and 86 (58%) of respondents, respectively. Responses to this question highlight that the onset of a pain flare and severity of a pain flare are clear priorities for respondents.

Fig 1. Survey respondents’ priorities relating to pain flares.

Fig 1

Respondents were prompted with the question: "If we could predict a pain flare, what specific information would you want to know?". Percentages of participants ranking each statement as their first, second, third, fourth, fifth or sixth priority are reported.

In free-text responses, nine respondents highlighted that they also wanted information about the triggers of their pain flare. Specific triggers that were cited were hormonal cycles, weather, environment and mood. One participant wanted information about the acceleration of the pain flare and one wanted information about medication to take during a flare.

Results of the priority-setting question “If we could predict a period of low pain severity, what specific information would you want to know?” are shown in Fig 2. The respondents ranked five statements. Onset of a period of low pain severity was first priority for 70 (47%) respondents. Respondents did not show great variability among the other responses. First or second priority was given to the duration of the period by 53 (36%) participants, to variation in other symptoms by 52 (35%) participants, to the end of the period by 50 (34%) participants, and to pain-related quality of life by 47 (32%) of participants. There was therefore only a clear priority for information about the onset of the period of low pain severity.

Fig 2. Survey respondents’ priorities relating to periods of low pain severity.

Fig 2

Respondents were prompted with the question: " If we could predict a period of low pain severity, what specific information would you want to know?". Percentages of participants ranking each statement as their first, second, third, fourth or fifth priority are reported.

Of the free-text responses, eight respondents referred to wanting information about the triggers of their low pain (e.g. barometric pressure) or variables that they could control (e.g., exercise). One participant wanted to understand how typical their experience is among others, one wanted information about treatments, and one wanted information about specific days.

Participants were asked the multiple-choice question: “If a pain forecast could provide useful information for you, do you think that you would use a pain forecast?” (Table 6). Of the 148 respondents, 113 (76%) would use a pain forecast. A chi-squared test of the responses from participants reporting fibromyalgia against those not reporting fibromyalgia gave a p-value of 0.2133. For the same question, a chi-squared test of the responses from participants reporting osteoarthritis against those not reporting osteoarthritis gave a p-value of 0.2133. Therefore, there is no evidence that the subgroups gave statistically significantly different responses to the population.

Table 6. Responses to the question: “If a pain forecast could provide useful information for you, do you think that you would use a pain forecast?”.

Response Number (and percentage) of full population who selected response Number (and percentage) of subgroup with fibromyalgia who selected response Number (and percentage) of subgroup with osteoarthritis who selected response
Definitely not 0 (0%) 0 (0%) 0 (0%)
Probably not 11 (7.4%) 2 (2.9%) 4 (8.2%)
Might or might not 24 (16.2%) 9 (13.2%) 8 (16.3%)
Probably yes 63 (42.6%) 27 (39.7%) 16 (32.7%)
Definitely yes 50 (33.8%) 30 (44.1%) 21 (42.9%)

All participants were also asked: “What would you use a pain forecast for?” (Table 7). The most common reasons were making plans (123, or 83%) and understanding individual triggers of chronic pain (113, or 76%). In addition, 70 (47%) and 46 (31%) respondents would use a pain forecast to plan pharmacological and nonpharmacological interventions, respectively. Therefore, making plans and understanding triggers are highlighted as the most likely benefits, although planning pharmacological and nonpharmacological interventions may also be of interest to a number of users.

Table 7. Responses to the question "What would you use a pain forecast for?" participants could select more than one option.

Pre-specified response Number of participants who selected response Percentage of participants who selected response
To help make plans (e.g. shopping, social) 123 83.1%
To understand the triggers of my pain 113 76.4%
To know when my pain severity might be better/worse 92 62.2%
To help plan nonpharmacological interventions 70 47.3%
To help choose which medication to take 46 31.1%
Other/None 16 10.8%

Relevant free-text responses were:

  • “To improve my overall self management of my conditions”

  • “To let work know times where I might need time off to recover so that it’s not out of the blue for them and they can prepare for me to be off if I need to”

  • “To analyse the development of my condition”

  • “Exercise planning”

  • “To help me understand my condition more”

  • “To look forward to some good times!”

Discussion

There are limitations to the PPI activities that should be considered. The representation of different conditions in our survey may have been impacted by the charities that shared the advertisements with their members, perhaps explaining the high prevalence of fibromyalgia among our respondents. This would impact the results if participants with certain conditions had different priorities to other people with chronic pain, and those conditions were over-represented in the surveyed population. However, sensitivity analyses among the subset of participants with fibromyalgia compared to the subset of participants without fibromyalgia, and the subset of participants with osteoarthritis compared to the subset of participants without osteoarthritis found no differences in the reported responses.

Recruitment advertisements clarified that participants would be commenting on a pain forecast, and respondents therefore had an interest in commenting on this topic. A large proportion of our survey participants were interested in a pain forecast and so the results may be less generalizable to those people who would initially be unsure or less inclined to use a forecast.

Both PPI activities recruited participants online, primarily due to the ongoing COVID-19 pandemic. A pain forecast may be implemented in a future digital intervention and users would then be required to access the internet. However, our work did not include participants who may be less inclined to use the internet for reasons including access and digital literacy. Our findings are therefore not generalizable to these populations and if a digital intervention is developed, work with these populations should be considered.

Previous work has reported on the longer-term prognosis of chronic pain. For example, some studies have followed people with chronic pain over several months or years and identified different trajectories of pain severity among people with chronic pain [45, 46]. Other studies have identified prognostic factors associated with chronic pain outcomes [47]. However, the participants in our focus group and survey have highlighted the importance of forecasting pain on a shorter-term, to support daily activities.

The benefits of a pain forecast extend previous work. Flurey et al. [23] reported that patients expressed frustration at the unpredictability of pain flares and this led to participants cancelling or altering plans. Fullen et al. [26] also found that individuals with chronic low-back pain reported missing out on social events and avoided making commitments, due to the unpredictability of their pain. Our work highlighted that respondents would value a forecast that reduced the unpredictability of their pain, particularly around the timing and severity of pain flares. Our participants highlighted the importance of making plans as a key benefit of a forecast, likely due to the frustration previously reported which has resulted in avoidance of making plans.

The drawbacks highlighted are also consistent with previous work. Among the challenges in collection and analysis of patient generated health data, privacy concerns have previously been highlighted [48], in line with concerns of focus group participants. Any future mobile application of a pain forecast should follow standards of privacy and security [49] and clearly communicate these to users. Furthermore, as pain is widely accepted within the biopsychosocial model [50], and rumination and catastrophizing are associated with increased pain severity [51], concerns around anticipatory anxiety should be thoughtfully considered.

These PPI activities indicated a high level of interest in a pain forecast and our participants were clear that pain features should include the timing of the start of a pain flare, the severity of a pain flare, and fluctuations in pain severity. Future work will develop a statistical pain forecasting model, to predict these identified features. As one of the key benefits of a pain forecast is the identification of triggers, a future model should be interpretable by its users. Drawbacks highlighted in the focus group, such as the impact of anticipatory anxiety should also be considered during the production of a forecast. Wider interest will be determined in the future, based on the uptake of a forecast and continued involvement of stakeholders and evaluation of a forecast will ensure that priorities indicated by participants translate into real value.

Conclusion

To understand whether individuals with chronic pain would be interested in forecasts of their pain, we conducted two patient and public involvement activities: a focus group of 12 participants and a survey of 148 other participants. These activities were focused on learning about the participants’ priorities in the features provided by a hypothetical pain forecast and understanding the perceived benefits that such forecasts would provide. The networks for 14 charities were used to find volunteers for the focus group and the survey.

Participants in the focus group identified the desire to predict the timing of the start of the periods of pain flares (when pain severity increased for a number of days) and their duration. The participants also wanted to know how the pain would affect their quality of life, which would allow them to better make plans, plan pharmacological interventions, and adapt work. Finally, the participants hoped that such hypothetical pain forecasts would help them understand the triggers of their pain, further empowering their ability to manage their disease and its effects. Participants also identified drawbacks to such forecasts, such as the anxiety of knowing of an upcoming pain event, recording their pain-severity scores leading to unnecessary focus on the pain, and the potential sharing of data with employers and the government.

The discussions within the focus group were used to construct a survey asking about the potential benefits and features of a hypothetical pain forecast. A total of 148 individuals responded to the survey. Most of the respondents reported their conditions as fibromyalgia (68, or 46%) and osteoarthritis (49, or 33%). When asked which features they desired in a pain forecast, pain flares (100, or 68%) and fluctuations in pain severity (94, or 64%) were the most commonly reported features. When asked if they would use a pain forecast, most respondents (113, or 76%) said they would. The responses to these questions were not statistically different for the subgroups with fibromyalgia or osteoarthritis relative to the respondents as a whole.

Respondents also identified their priorities for what a pain forecast would include. Most popular features were onset, severity, and duration of a pain flare. When asked what they would use a pain forecast for, respondents replied with their most common reasons: making plans (123, or 83%), understanding individual triggers of chronic pain (113, or 76%), and knowing when their pain severity might be better or worse (92, or 62%). In addition, 70 (47%) and 46 (31%) respondents would use a pain forecast to plan pharmacological and nonpharmacological interventions, respectively.

The results of the focus group and survey indicate the potential for forecasts of pain for those living with chronic pain and what the features of such forecasts might be. Some commercial weather-forecasting companies have smartphone applications that provide pain forecasts based on unspecified algorithms, so this desire is already being met. Nevertheless, our results provide more insight into the benefits that the forecasts would provide to respondents through using these forecasts, as well as their concerns for their mental health knowing about potential future pain flares and their concerns for how the data would be used and who would have access to it.

Supporting information

S1 Data. Survey to participants.

(PDF)

Acknowledgments

We are grateful for the contributions of the members of the Patient and Public Involvement focus group and the respondents to the survey. We thank Prof. Premalatha Paulsamy and an anonymous reviewer for comments that improved an earlier version of this manuscript.

Data Availability

The datasets generated and analysed during the current study are not publicly available as data were collected for patient and public involvement activities and consent was obtained for the sharing of anonymous quotes and aggregated data only. The data within the Cloudy with a Chance of Pain study is detailed health data for a national population and is both sensitive and special category data. Given the detailed nature of the dataset, it is not possible to provide a minimal de-identified dataset that retains the necessary data utility to replicate our study’s findings and be considered anonymised. Anonymisation of the Cloudy study data (whilst retaining data utility) is only possible through a combination of measures [i.e., de-identification, data minimisation related to the use case and the provision of access via a Secure Data Environment (SDE)]. These measures are in line with the UK Anonymisation Network guidance (Elliot, Mackey, & O’Hara, 2020). We are currently working towards establishing the processes for supporting access and sharing via an SDE and anticipate the data will be more widely sharable sometime in 2024. Elaine Mackey is the contact for dataset access (elaine.mackey@manchester.ac.uk).

Funding Statement

This work was supported by infrastructure support from the Centre for Epidemiology Versus Arthritis (grant number 21755; https://www.versusarthritis.org/research/our-current-research/our-research-centres/ [versusarthritis.org]). TH receives funding from the Royal Society (grant number INF/R2/180067; https://royalsociety.org/ [royalsociety.org]) and the Alan Turing Institute for Data Science and Artificial Intelligence (https://www.turing.ac.uk/ [turing.ac.uk]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.McQueenie R, Jani BD, Siebert S, McLoone P, McCowan C, Macdonald S, et al. Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank. J Multimorb Comorbidity. 2021. Jan 1;11:263355652110058. doi: 10.1177/26335565211005870 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016. May;6(6):e010364. doi: 10.1136/bmjopen-2015-010364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015. Aug;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chen S, Chen M, Wu X, Lin S, Tao C, Shao Z, et al. Global, regional, and national burden of low back pain 1990–2019: A systematic analysis of the Global Burden of Disease study 2019. J Orthopaedic Translation. 2022, 32:49–58. doi: 10.1016/j.jot.2021.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hadi MA, McHugh GA, Closs SJ. Impact of Chronic Pain on Patients’ Quality of Life: A Comparative Mixed-Methods Study. J Patient Exp. 2019. Jun;6(2):133–41. doi: 10.1177/2374373518786013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Office for National Statistics. Sickness absence in the UK labour market: 2021 [Internet]. 2022 Apr [cited 2022 Aug 9]. https://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/labourproductivity/articles/sicknessabsenceinthelabourmarket/2021
  • 7.Barham L. Economic Burden of Chronic Pain Across Europe. J Pain Palliat Care Pharmacother. 2012. Mar 7;26(1):70–2. [Google Scholar]
  • 8.Leadley RM, Armstrong N, Reid KJ, Allen A, Misso KV, Kleijnen J. Healthy aging in relation to chronic pain and quality of life in Europe. Pain Pract Off J World Inst Pain. 2014. Jul;14(6):547–58. doi: 10.1111/papr.12125 [DOI] [PubMed] [Google Scholar]
  • 9.Mutubuki EN, Beljon Y, Maas ET, Huygen FJPM, Ostelo RWJG, van Tulder MW, et al. The longitudinal relationships between pain severity and disability versus health-related quality of life and costs among chronic low back pain patients. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2020. Jan;29(1):275–87. doi: 10.1007/s11136-019-02302-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007. Apr 10;68(15):1178–82. doi: 10.1212/01.wnl.0000259085.61898.9e [DOI] [PubMed] [Google Scholar]
  • 11.Fonseca-Rodrigues D, Rodrigues A, Martins T, Pinto J, Amorim D, Almeida A, et al. Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis. Rheumatol Oxf Engl. 2021. Dec 24;61(1):53–75. doi: 10.1093/rheumatology/keab512 [DOI] [PubMed] [Google Scholar]
  • 12.Bonilla-Jaime H, Sánchez-Salcedo JA, Estevez-Cabrera MM, Molina-Jiménez T, Cortes-Altamirano JL, Alfaro-Rodríguez A. Depression and Pain: Use of Antidepressants. Curr Neuropharmacol. 2022;20(2):384–402. doi: 10.2174/1570159X19666210609161447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stubbs B, Vancampfort D, Veronese N, Thompson T, Fornaro M, Schofield P, et al. Depression and pain: primary data and meta-analysis among 237 952 people across 47 low- and middle-income countries. Psychol Med. 2017. Dec;47(16):2906–17. [DOI] [PubMed] [Google Scholar]
  • 14.Froud R, Patterson S, Eldridge S, Seale C, Pincus T, Rajendran D, et al. A systematic review and meta-synthesis of the impact of low back pain on people’s lives. BMC Musculoskelet Disord. 2014. Feb 21;15:50. doi: 10.1186/1471-2474-15-50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cancelliere C, Donovan J, Stochkendahl MJ, Biscardi M, Ammendolia C, Myburgh C, et al. Factors affecting return to work after injury or illness: best evidence synthesis of systematic reviews. Chiropr Man Ther. 2016;24(1):32. doi: 10.1186/s12998-016-0113-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Austin L, Sharp CA, van der Veer SN, Machin M, Humphreys J, Mellor P, et al. Providing ‘the bigger picture’: benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record. Rheumatology. 2020. Feb 1;59(2):367–78. doi: 10.1093/rheumatology/kez207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Allen KD, Coffman CJ, Golightly YM, Stechuchak KM, Keefe FJ. Daily pain variations among patients with hand, hip, and knee osteoarthritis. Osteoarthritis Cartilage. 2009. Oct;17(10):1275–82. doi: 10.1016/j.joca.2009.03.021 [DOI] [PubMed] [Google Scholar]
  • 18.Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018. Apr;19(4):372–81. doi: 10.1016/j.jpain.2017.11.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Toussaint L, Vincent A, McAllister SJ, Whipple M. Intra- and Inter-Patient Symptom Variability in Fibromyalgia: Results of a 90-Day Assessment: Symptom Variability in Fibromyalgia. Musculoskeletal Care. 2015. Jun;13(2):93–100. [DOI] [PubMed] [Google Scholar]
  • 20.Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, et al. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005. Nov;52(11):3670–4. doi: 10.1002/art.21407 [DOI] [PubMed] [Google Scholar]
  • 21.Vives‐Mestres M, Casanova A, Hershey AD, Orr SL. Perceived stress and pain severity in individuals with chronic migraine: A longitudinal cohort study using daily prospective diary data. Headache J Head Face Pain. 2021. Sep;61(8):1245–54. [DOI] [PubMed] [Google Scholar]
  • 22.Houle TT, Penzien DB, Rains JC. Time‐Series Features of Headache: Individual Distributions, Patterns, and Predictability of Pain. Headache J Head Face Pain. 2005. May;45(5):445–58. doi: 10.1111/j.1526-4610.2005.05096.x [DOI] [PubMed] [Google Scholar]
  • 23.Flurey CA, Morris M, Richards P, Hughes R, Hewlett S. It’s like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes. Rheumatology. 2014. Apr 1;53(4):696–703. doi: 10.1093/rheumatology/ket416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Darlow B, Brown M, Thompson B, Hudson B, Grainger R, McKinlay E, et al. Living with osteoarthritis is a balancing act: an exploration of patients’ beliefs about knee pain. BMC Rheumatol. 2018. Dec;2(1):15. doi: 10.1186/s41927-018-0023-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hutchings A, Calloway M, Choy E, Hooper M, Hunter DJ, Jordan JM, et al. The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomes. J Rheumatol. 2007. Nov;34(11):2291–300. [PubMed] [Google Scholar]
  • 26.Fullen B, Morlion B, Linton SJ, Roomes D, Griensven J, Abraham L, et al. Management of chronic low back pain and the impact on patients’ personal and professional lives: Results from an international patient survey. Pain Pract. 2022. Feb 25;papr.13103. doi: 10.1111/papr.13103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kolber MR, Ton J, Thomas B, Kirkwood J, Moe S, Dugré N, et al. PEER systematic review of randomized controlled trials: Management of chronic low back pain in primary care. Can Fam Physician Med Fam Can. 2021. Jan;67(1):e20–30. doi: 10.46747/cfp.6701e20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Antcliff D, Campbell M, Woby S, Keeley P. Activity Pacing is Associated With Better and Worse Symptoms for Patients With Long-term Conditions. Clin J Pain. 2017. Mar;33(3):205–14. doi: 10.1097/AJP.0000000000000401 [DOI] [PubMed] [Google Scholar]
  • 29.George SZ, Parr JJ, Wallace MR, Wu SS, Borsa PA, Dai Y, et al. Biopsychosocial Influence on Exercise-Induced Injury: Genetic and Psychological Combinations Are Predictive of Shoulder Pain Phenotypes. J Pain. 2014. Jan;15(1):68–80. doi: 10.1016/j.jpain.2013.09.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. J Affect Disord. 2017. Oct 15;221:36–46. doi: 10.1016/j.jad.2017.06.009 [DOI] [PubMed] [Google Scholar]
  • 31.McBeth J, Dixon WG, Moore SM, Hellman B, James B, Kyle SD, et al. Sleep Disturbance and Quality of Life in Rheumatoid Arthritis: Prospective mHealth Study. J Med Internet Res. 2022. Apr 22;24(4):e32825. doi: 10.2196/32825 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Yimer BB, Schultz DM, Beukenhorst AL, Lunt M, Pisaniello HL, House T, et al. Heterogeneity in the association between weather and pain severity among patients with chronic pain: a Bayesian multilevel regression analysis. PAIN Rep. 2022. Jan;7(1):e963. doi: 10.1097/PR9.0000000000000963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Druce KL, Dixon WG, McBeth J. Maximizing Engagement in Mobile Health Studies: Lessons Learned and Future Directions. Rheum Dis Clin North Am. 2019. May;45(2):159–72. doi: 10.1016/j.rdc.2019.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gandrup J, Selby DA, van der Veer SN, Mcbeth J, Dixon WG. Using patient-reported data from a smartphone app to capture and characterize real-time patient-reported flares in rheumatoid arthritis. Rheumatol Adv Pract. 2022;6(1):rkac021. doi: 10.1093/rap/rkac021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lordon RJ, Mikles SP, Kneale L, Evans HL, Munson SA, Backonja U, et al. How patient-generated health data and patient-reported outcomes affect patient-clinician relationships: A systematic review. Health Informatics J. 2020. Dec;26(4):2689–706. doi: 10.1177/1460458220928184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020. Apr 7;369:m1328. doi: 10.1136/bmj.m1328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Moshe I, Terhorst Y, Opoku Asare K, Sander LB, Ferreira D, Baumeister H, et al. Predicting Symptoms of Depression and Anxiety Using Smartphone and Wearable Data. Front Psychiatry. 2021. Jan 28;12:625247. doi: 10.3389/fpsyt.2021.625247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Voukantsis D, Berger U, Tzima F, Karatzas K, Jaeger S, Bergmann KC. Personalized symptoms forecasting for pollen-induced allergic rhinitis sufferers. Int J Biometeorol. 2015. Jul;59(7):889–97. doi: 10.1007/s00484-014-0905-6 [DOI] [PubMed] [Google Scholar]
  • 39.Hajifar S, Sun H, Megahed FM, Jones-Farmer LA, Rashedi E, Cavuoto LA. A forecasting framework for predicting perceived fatigue: Using time series methods to forecast ratings of perceived exertion with features from wearable sensors. Appl Ergon. 2021. Jan;90:103262. doi: 10.1016/j.apergo.2020.103262 [DOI] [PubMed] [Google Scholar]
  • 40.INVOLVE. Briefing notes for researchers: involving the public in NHS, public health and social care research. INVOLVE, Eastleigh; 2012.
  • 41.Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. 2017. Aug 2;j3453. doi: 10.1136/bmj.j3453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.O’Cathain A, Croot L, Sworn K, Duncan E, Rousseau N, Turner K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasibility Stud. 2019. Dec;5(1):41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kitzinger J. Qualitative Research: Introducing focus groups. BMJ. 1995. Jul 29;311(7000):299–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.National Institute for Health and Care Research. Reward and recognition for public contributors—a guide to the payment of fees and expenses [Internet]. 2021 [cited 2021 Jul 1]. https://www.nihr.ac.uk/documents/reward-and-recognition-for-public-contributors-a-guide-to-the-payment-of-fees-and-expenses/12248
  • 45.Kongsted A, Kent P, Axen I, Downie AS, Dunn KM. What have we learned from ten years of trajectory research in low back pain? BMC Musculoskelet Disord. 2016. 21;17:220. doi: 10.1186/s12891-016-1071-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Previtali D, Andriolo L, Di Laura Frattura G, Boffa A, Candrian C, Zaffagnini S, et al. Pain Trajectories in Knee Osteoarthritis-A Systematic Review and Best Evidence Synthesis on Pain Predictors. J Clin Med. 2020. Sep 1;9(9):E2828. doi: 10.3390/jcm9092828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Nieminen LK, Pyysalo LM, Kankaanpää MJ. Prognostic factors for pain chronicity in low back pain: a systematic review. PAIN Rep. 2021;6(1):e919. doi: 10.1097/PR9.0000000000000919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bourke A, Dixon WG, Roddam A, Lin KJ, Hall GC, Curtis JR, et al. Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiol Drug Saf. 2020. Dec;29(12):1540–9. doi: 10.1002/pds.5169 [DOI] [PubMed] [Google Scholar]
  • 49.Mandl KD, Mandel JC, Kohane IS. Driving Innovation in Health Systems through an Apps-Based Information Economy. Cell Syst. 2015. Jul;1(1):8–13. doi: 10.1016/j.cels.2015.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019. Jan;160(1):19–27. doi: 10.1097/j.pain.0000000000001384 [DOI] [PubMed] [Google Scholar]
  • 51.Meints SM, Edwards RR. Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol Biol Psychiatry. 2018. Dec;87:168–82. doi: 10.1016/j.pnpbp.2018.01.017 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Shadia Hamoud Alshahrani

8 Aug 2023

PONE-D-23-13975What do people living with chronic pain want from a pain forecast? A research prioritization studyPLOS ONE

Dear Dr. Schultz,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shadia Hamoud Alshahrani, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

"This work was supported by infrastructure support from the Centre for Epidemiology Versus Arthritis (grant number 21755; https://www.versusarthritis.org/research/our-current-research/our-research-centres/). TH receives funding from the Royal Society (grant number INF/R2/180067; https://royalsociety.org/) and the Alan Turing Institute for Data Science and Artificial Intelligence (https://www.turing.ac.uk/). "

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Competing Interests section:

"WGD has received consultancy fees from Google (google.com), and DMS has received consultancy fees from Palta (https://palta.com/), both unrelated to this work. All other authors have declared that no competing interests exist."

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.   

In your revised cover letter, please address the following prompts:

    a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

   b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article needs major enhancement especially for data presentation, results, intext referencing, major work needs to be done, perhapse rewriting at this point and resubmit it again. Also you need to focus on presenting the data in more than a percentage.

Reviewer #2: Overall, it is a unique study and gives scientific insight into the fraternity on the development of the pain forecast model.

1. Title: The title of the manuscript is appropriate.

2. Introduction: In line no. 36, 37, It would be better to include the most recent references which will give more strength to the need for the study.

3. Study Design: It is unclear from the abstract what is the type and design. It would be helpful to clarify the study design and approach.

4. Methods Section: The methods section lacks important details regarding the study sample selection.

• Is there any matching done according to the sample characteristics

• How the survey question was validated

• In which way, the survey was questionnaire was administered

Please clearly the above quarries.

5. Analysis of data: It is unclear how the data was analyzed. Kindly elaborate on it.

7. Conclusion Section: Consider discussing the implications of the study's findings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: PREMALATHA PAULSAMY

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Shadia Hamoud Alshahrani

3 Oct 2023

What do people living with chronic pain want from a pain forecast? A research prioritization study

PONE-D-23-13975R1

Dear Dr. David M. Schultz

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shadia Hamoud Alshahrani, PhD

Academic Editor

PLOS ONE

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Shadia Hamoud Alshahrani

5 Oct 2023

PONE-D-23-13975R1

What do people living with chronic pain want from a pain forecast? A research prioritization study

Dear Dr. Schultz:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shadia Hamoud Alshahrani

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Survey to participants.

    (PDF)

    Attachment

    Submitted filename: Response2Reviewers-R2.docx

    Data Availability Statement

    The datasets generated and analysed during the current study are not publicly available as data were collected for patient and public involvement activities and consent was obtained for the sharing of anonymous quotes and aggregated data only. The data within the Cloudy with a Chance of Pain study is detailed health data for a national population and is both sensitive and special category data. Given the detailed nature of the dataset, it is not possible to provide a minimal de-identified dataset that retains the necessary data utility to replicate our study’s findings and be considered anonymised. Anonymisation of the Cloudy study data (whilst retaining data utility) is only possible through a combination of measures [i.e., de-identification, data minimisation related to the use case and the provision of access via a Secure Data Environment (SDE)]. These measures are in line with the UK Anonymisation Network guidance (Elliot, Mackey, & O’Hara, 2020). We are currently working towards establishing the processes for supporting access and sharing via an SDE and anticipate the data will be more widely sharable sometime in 2024. Elaine Mackey is the contact for dataset access (elaine.mackey@manchester.ac.uk).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES